JUL 17, 2020 8:37 AM PDT

Could Low-Dose Radiation Therapy Treat COVID-19?

WRITTEN BY: Annie Lennon

Research from a century ago points towards the potential of low-dose radiation therapy (LDRT) for treating pneumonia. Even though studies reported symptoms to subside within just a few hours of a single X-ray, doctors took little notice. Now, amid the COVID-19 pandemic, new interest is gathering around the controversial research. 

"Back in February, I started getting just dozens and dozens and dozens of emails from radiation oncologists —people who treat cancer patients with targeted radiation. And they had come across our paper and they thought that this might be a vehicle by which they could help suffering and dying Covid patients perhaps survive," says toxicologist Edward Calabrese, from the University of Massachusets, who wrote a paper on the potential of radiation therapy in 2013. 

There are currently at least a dozen trials worldwide investigating the impact of LDRT in treating pneumonia from COVID-19. In countries including Italy, Iran, India, and the US, studies are recruiting between five and 106 COVID-19 patients with pneumonia, under the condition that half are at least 40 years old. 

The theory goes that targeted radiation to the lungs can prevent inflammation from getting out of control in what's known as a 'cytokine storm'- one of the leading causes for deaths by COVID-19. To do so, some hypothesize that LDRT may be able to 'flick a switch' inside immune cells, so that they become anti-inflammatory instead. 

Despite some hope that the treatment may work, experts are divided. While some are optimistic, others say that the radiation may in fact, exacerbate respiratory damage and perhaps introduce a cancer risk. Others say that patients partaking in this treatment may miss out on more promising treatments. 

Some interim results however from a clinical trial of 10 patients with COVID-19 at Emory University seem positive. All of the first five patients at an average of 90 years old or over were alive two weeks following treatment and no longer needed oxygen within 24 hours of LDRT. 

While promising results for some, others remain unconvinced. Ralph Weichselbaum, a radiation oncologist at the University of Chicago, said, "No one's going to be able to tell if it worked or not, unless it's a huge trial. By that time there will be some other treatment like steroids, which is a lot less dangerous and makes a lot more sense and is a lot more scientifically based... It's not thought-out. It's not of value. I don't take anything from these cases."

 

Sources: StatnewsmedRxiv

About the Author
  • Science writer with a keen interest in behavioral biology, consciousness medicine and technology. Her current focus is how the interplay of these fields can create meaningful interactions, products and environments.
You May Also Like
JAN 21, 2021
Health & Medicine
Injectable Cannabis Overdose Drug Being Developed
JAN 21, 2021
Injectable Cannabis Overdose Drug Being Developed
It’s estimated that the number of visits to emergency rooms because of cannabis overdose tripled between 2011 and ...
FEB 10, 2021
Cannabis Sciences
Cannabis Lowers Blood Pressure in Older Adults
FEB 10, 2021
Cannabis Lowers Blood Pressure in Older Adults
Researchers from Ben-Gurion University of the Negev (BGU) in Israel have found that medical cannabis may reduce blood pr ...
FEB 26, 2021
Microbiology
Good Bacteria Fights Bad Bacteria in a Clinical Trial
FEB 26, 2021
Good Bacteria Fights Bad Bacteria in a Clinical Trial
Eczema is a skin condition that causes a chronic, itchy rash. The most common form of the disorder, atopic dermatitis, i ...
MAR 02, 2021
Immunology
Another Trick up Tumors' Sleeves Exposed
MAR 02, 2021
Another Trick up Tumors' Sleeves Exposed
Tumors have sneaky strategies for establishing themselves within healthy tissues, flourishing in plain sight of circulat ...
MAR 05, 2021
Drug Discovery & Development
Personalized Treatment for Sickle Cell Disease
MAR 05, 2021
Personalized Treatment for Sickle Cell Disease
Globally, the most prevalent inherited blood disease is sickle cell which affects 70,000 to 100,000 Americans. Despite s ...
APR 13, 2021
Immunology
The "Unexpected" Reason Why COVID Antivirals Don't Work
APR 13, 2021
The "Unexpected" Reason Why COVID Antivirals Don't Work
Purdue University researchers have made a breakthrough finding that could explain why the disease is so hard to manage t ...
Loading Comments...